{"count": 5, "results": [{"_id": "33342103", "pmid": 33342103, "title": "[Family diabetes and main noncommunicable diseases: The described and potential effect of metformin (remembering Vladimir Dilman).]", "journal": "Adv Gerontol", "authors": ["Berstein LM"], "date": "2020-01-01T00:00:00Z", "meta_date_publication": "2020", "meta_volume": "33", "meta_issue": "4", "meta_pages": "713-720", "score": 50264.78, "text_hl": "[@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Family diabetes@@@ and main @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@noncommunicable diseases@@@: The described and potential effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (remembering Vladimir Dilman).]", "citations": {"NLM": "Berstein LM. [Family diabetes and main noncommunicable diseases: The described and potential effect of metformin (remembering Vladimir Dilman).] Adv Gerontol. 2020;33(4):713-720. PMID: 33342103", "BibTeX": "@article{33342103, title={[Family diabetes and main noncommunicable diseases: The described and potential effect of metformin (remembering Vladimir Dilman).]}, author={Berstein LM}, journal={Adv Gerontol}, volume={33}, number={4}, pages={713-720}}"}}, {"_id": "33683184", "pmid": 33683184, "title": "Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database.", "journal": "Ocul Immunol Inflamm", "authors": ["Sobrin L", "Yu Y", "Han S", "Susarla G", "Kempen JH", "Hubbard RA", "VanderBeek BL"], "date": "2022-08-01T00:00:00Z", "doi": "10.1080/09273948.2021.1872650", "meta_date_publication": "2022 Aug", "meta_volume": "30", "meta_issue": "6", "meta_pages": "1334-1340", "score": 50264.598, "text_hl": "PURPOSE: To determine if @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is associated with @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@noninfectious@@@ @DISEASE_Uveitis @DISEASE_MESH:D014605 @@@uveitis@@@ (@<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@NIU@@@). ", "citations": {"NLM": "Sobrin L, Yu Y, Han S, Susarla G, Kempen JH, Hubbard RA, VanderBeek BL. Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database. Ocul Immunol Inflamm. 2022 Aug;30(6):1334-1340. PMID: 33683184", "BibTeX": "@article{33683184, title={Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database.}, author={Sobrin L and Yu Y and Han S and Susarla G and Kempen JH and Hubbard RA and VanderBeek BL}, journal={Ocul Immunol Inflamm}, volume={30}, number={6}, pages={1334-1340}}"}}, {"_id": "28106245", "pmid": 28106245, "title": "A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome.", "journal": "Tumori", "authors": ["Pasanisi P", "Gargano G", "Gaetana Di Mauro M", "Cortellini M", "Casagrande A", "Villarini A", "Bruno E", "Roveda E", "Saibene G", "Venturelli E", "Berrino F"], "date": "2018-03-01T00:00:00Z", "doi": "10.5301/tj.5000599", "meta_date_publication": "2018 Mar-Apr", "meta_volume": "104", "meta_issue": "2", "meta_pages": "137-142", "score": 50055.156, "text_hl": "We designed a phase III randomized controlled trial (the Me.Me.Me trial) to evaluate the effect of a comprehensive lifestyle intervention (including moderate physical activity and a Mediterranean-macrobiotic diet) and the effect of treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the prevention of @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@ArCDs@@@ in healthy people with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MetS.@@@ This report describes the scientific protocol of this trial. ", "citations": {"NLM": "Pasanisi P, Gargano G, Gaetana Di Mauro M, Cortellini M, Casagrande A, Villarini A, Bruno E, Roveda E, Saibene G, Venturelli E, Berrino F. A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome. Tumori. 2018 Mar-Apr;104(2):137-142. PMID: 28106245", "BibTeX": "@article{28106245, title={A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome.}, author={Pasanisi P and Gargano G and Gaetana Di Mauro M and Cortellini M and Casagrande A and Villarini A and Bruno E and Roveda E and Saibene G and Venturelli E and Berrino F}, journal={Tumori}, volume={104}, number={2}, pages={137-142}}"}}, {"_id": "31196078", "pmid": 31196078, "pmcid": "PMC6567665", "title": "Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology", "journal": "BMC Health Serv Res", "authors": ["Kasonde L", "Tordrup D", "Naheed A", "Zeng W", "Ahmed S", "Babar ZU"], "date": "2019-06-13T00:00:00Z", "doi": "10.1186/s12913-019-4221-z", "meta_date_publication": "2019 Jun 13", "meta_volume": "19", "meta_issue": "1", "meta_pages": "383", "score": 50043.582, "text_hl": "Availability and affordability of @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@NCD@@@ medicines are key concerns where the burden of @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@NCD@@@ is rising. ", "citations": {"NLM": "Kasonde L, Tordrup D, Naheed A, Zeng W, Ahmed S, Babar ZU. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology BMC Health Serv Res. 2019 Jun 13;19(1):383. PMID: 31196078", "BibTeX": "@article{31196078, title={Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology}, author={Kasonde L and Tordrup D and Naheed A and Zeng W and Ahmed S and Babar ZU}, journal={BMC Health Serv Res}, volume={19}, number={1}, pages={383}}"}}, {"_id": "30794607", "pmid": 30794607, "pmcid": "PMC6386477", "title": "A management system for randomized clinical trials: A novel way to supply medication", "journal": "PLoS One", "authors": ["Cortellini M", "Casagrande A", "Fornaciari G", "Del Sette D", "Gargano G", "Di Mauro MG", "Saibene G", "Bruno E", "Villarini A", "Venturelli E", "Berrino F", "Baldassari I", "Oliverio A", "Pasanisi P"], "date": "2019-02-22T00:00:00Z", "doi": "10.1371/journal.pone.0212475", "meta_date_publication": "2019", "meta_volume": "14", "meta_issue": "2", "meta_pages": "e0212475", "score": 50041.027, "text_hl": "Me.Me.Me. is an ongoing phase III randomized controlled trial in healthy people with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ to test the hypothesis that comprehensive lifestyle changes and/or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can prevent age-related chronic @<m>DISEASE_Noncommunicable_Diseases</m> @DISEASE_MESH:D000073296 @@@non-communicable diseases@@@. ", "citations": {"NLM": "Cortellini M, Casagrande A, Fornaciari G, Del Sette D, Gargano G, Di Mauro MG, Saibene G, Bruno E, Villarini A, Venturelli E, Berrino F, Baldassari I, Oliverio A, Pasanisi P. A management system for randomized clinical trials: A novel way to supply medication PLoS One. 2019;14(2):e0212475. PMID: 30794607", "BibTeX": "@article{30794607, title={A management system for randomized clinical trials: A novel way to supply medication}, author={Cortellini M and Casagrande A and Fornaciari G and Del Sette D and Gargano G and Di Mauro MG and Saibene G and Bruno E and Villarini A and Venturelli E and Berrino F and Baldassari I and Oliverio A and Pasanisi P}, journal={PLoS One}, volume={14}, number={2}, pages={e0212475}}"}}]}